Acta Pharmaceuticals
Acta Pharmaceuticals focused on developing new therapies for early intervention and prevention of Alzheimer's disease.
$24M Seed ·
Source: citybiz.co
Funding history ↓About Acta Pharmaceuticals
Acta Pharmaceuticals is a company based in Boston, United States. Recent Funding lists it under Health and bio (also Manufacturing and industrial). It raised $24M in a Seed round in October 2026, according to citybiz.co. Investors on record include Alzheimer's Research Foundation, Dolby Family Ventures and Gamma Biosciences. It was founded by Rudolph E. Tanzi.
Funding rounds
- Seed · $24MSource: citybiz.co
- Website created
Founders and team
- RERudolph E. Tanzi Scientific Foundersource: actapharmaceuticals.com
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
CCureBay$10.55M Series B+ · Oct 2026
Questions and sources
Acta Pharmaceuticals: questions and answers
- How much has Acta Pharmaceuticals raised?
- Acta Pharmaceuticals has raised $24M in one sourced round on record (Seed), announced October 15, 2026.
- Who invested in Acta Pharmaceuticals?
- Investors on record for Acta Pharmaceuticals: Alzheimer's Research Foundation, Dolby Family Ventures and Gamma Biosciences.
- Who founded Acta Pharmaceuticals?
- Acta Pharmaceuticals was founded by Rudolph E. Tanzi (Scientific Founder).
- Where is Acta Pharmaceuticals based?
- Acta Pharmaceuticals is based in Boston, United States.
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/acta-pharmaceuticals (get a free API key).